Find your next paid study

Mayo ClinicNCT05584449

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

This clinical trial assesses whether resource identification for primary caregivers can affect financial stress, quality of life, depression, and the general b…

Wake Forest University Health SciencesNCT06709404

Outcomes After Chimeric Antigen Receptor Therapy (CAR-T) and Radiation Therapy (RT) for Hematologic Malignancies

This study collects information on outcomes after chimeric antigen receptor therapy and radiation therapy for hematologic malignancies. Collecting information …

Hematopoietic and Lymphoid Cell Neoplasm

M.D. Anderson Cancer CenterNCT04888338

~$10 – $750

Phase 1

Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)

The purpose of this Phase 1, first in human open-label study is to assess the safety and tolerability of TRX-103 in patients with hematological malignancies un…

Hematologic MalignancyGvHDGVHD,Acute+8 more

~$10 – $8,750

Tr1X, Inc.NCT06462365

Myeloid MalignancyInherited Bone Marrow Failure SyndromeClonal Expansion+10 more

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NG…

Cytomegaloviral InfectionHematopoietic Cell Transplant Recipient

Mayo ClinicNCT02958462

Phase 1

A Phase 1/2 Clinical Study to Evaluate the Optimal Dose and the Protective Effect of CMV-MVA Triplex Vaccine in Pediatric Patients Receiving an Allogeneic Hematopoietic Stem Cell Transplant

This phase I/II trial studies the side effects and best dose of multi-antigen cytomegalovirus (CMV)-modified vaccinia ankara vaccine and to see how well it wor…

City of Hope Medical CenterNCT03354728

Phase 2

A Phase 2 Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Narsoplimab in Pediatric Patients (28 Days to ≤ 18 Years of Age.) With High-Risk Hematopoietic Stem Cell Transplant Thrombotic Microangiopathy

The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematop…

Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation

Omeros CorporationNCT05855083

~$10 – $8,750

Hematopoietic Stem Cell Transplant

Cardio-Oncology Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

To assess the feasibility and preliminary effectiveness of a Cardio-Oncology Prehabilitation program in patients at high-risk of developing Cardiovascular (CV)…

University of Michigan Rogel Cancer CenterNCT05945121

Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer

This study uses ambient sensing rooms to collect data from hospitalized cancer patients in order to improve safety and recovery. Being hospitalized increases t…

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more

~$10 – $750

Mayo ClinicNCT07477886

Phase 2

Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where i…

Phase 2

ECHO Telementoring to Improve Quality Palliative Care in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregi…

Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm

M.D. Anderson Cancer CenterNCT04984551

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm

Communication Issues in Patient/Provider Discussions of Immunotherapy

This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have hea…